+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 0 - 17Years
All Genders
ID06070350

Massive Transfusion in Children Comparing Whole Blood and Component Therapy with Tranexamic Acid or Placebo in Severe Traumatic Bleeding

Led by Philip Spinella · Updated on 2026-09-17

1000

Participants Needed

23

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatments for children under 18 years old who experience life-threatening bleeding from traumatic injury. This trial aims to compare Low Titer Group O Whole Blood LTOWB with standard Component Therapy CT, as well as Tranexamic Acid TXA with a placebo, to determine their effects on reducing death within 24 hours after injury. The study also assesses safety outcomes like organ failure, infections, and blood clotting problems. Children enrolled in this randomized trial receive one of four combinations LTOWB with TXA, LTOWB with placebo, CT with TXA, or CT with placebo. LTOWB is blood from group O donors with low antibody levels, while CT includes red blood cells, plasma, and platelets given in a 111 ratio. TXA is given intravenously or intraosseously at a dose of 25 mgkg up to 2 grams to help prevent excessive bleeding. Up to 8 units of LTOWB may be given depending on clinical practice. During the study, participants are closely monitored for survival at various intervals including 6 hours, 24 hours, 72 hours, and 28 days. Researchers also track blood transfusion volumes within 24 hours and assess safety outcomes such as kidney injury, respiratory distress, heart problems, infections, and immune reactions. Blood and other samples are collected to study trauma-induced blood clotting disorders and how treatments affect these conditions. The trial is expected to continue through 2028, with participant follow-up lasting up to 28 days after treatment.

CONDITIONS

Brief Title

Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

Research Team

T

Thomas Byers

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here